OptraSCAN® announces Dr. Jon S. Morrow’s appointment to Medical Advisory Board
San Jose, CA, January 9th, 2019: OptraSCAN®, the leading On-Demand Digital Pathology solution provider announced the appointment of Dr. Jon S. Morrow, M.D., Ph.D., Raymond Yesner Professor & Chair, Department of Pathology – Yale School of Medicine, Professor of Molecular Cellular & Departmental Biology, Yale University, and Chief of Pathology, Yale New Haven Hospital; as a member of OptraSCAN’s Medical Advisory Board. Dr. Morrow brings more than thirty years of experience in the field of pathology.
An internationally recognized physician-scientist, Dr. Morrow’s research has pioneered studies on the structure, function and genetics of complex cell membrane scaffolds. These studies were among the first to reveal the molecular basis of several hereditary disorders of blood cells, diseases most commonly afflicting young children, as well as the molecular basis of movement disorders such as hereditary ataxia. This work is reported in over 200 original research publications and reviews. Dr. Morrow personally co-authored the development of the first comprehensive anatomic pathology information system (CoPath®), now the most widely used anatomic lab information system across the Country.
“I am delighted to join the OptraSCAN Medical Advisory Board. Digital imaging will transform our discipline over the next 5-10 years. OptraSCAN’s goal to bring this capability to all pathologists, regardless of the size of their practice, will be an important enabler of this transformation. My participation reflects my commitment to seeing this goal achieved”, said Dr. Jon Morrow, M.D., Ph.D.
“We are thrilled to have Dr. Morrow join our Medical Advisory Board, and we look forward to his contributions,” said Abhi Gholap, Founder & CEO, OptraSCAN. “Dr. Morrow brings to us profound experience in leading and developing new technologies in the pathology field. His addition will enhance our expertise in providing affordable digital pathology for the benefit of every human and further strengthen our board to support OptraSCAN’s growth opportunities.”
OptraSCAN’s prestigious Medical Advisory Board includes Dr. Jiaoti Huang, MD, PhD Professor and Chairman of Department of Pathology, Professor of Pharmacology and Cancer Biology at Duke University; Dr. Michael C. Montalto, PhD, Executive Director and Head of Translational Pathology and Biomarker Sciences in Translational Medicine at Bristol-Myer Squibb; Dr. Allen Gown, MD, Medical Director at PhenoPath Laboratories; Dr. Abul Abbas, MD, Distinguished Professor and Chair, Department of Pathology, University of California San Francisco.
About OptraSCAN, Inc.
An ISO 13485 certified company and CE marked whole slide scanners for IVD use, OptraSCAN® are pioneers in the On-Demand Digital Pathology® System; focused on delivering fully integrated, affordable systems & solutions to serve as the perfect tool for transition from conventional microscopy to Digital Pathology for the effective acquisition of whole slide images, viewing, storing, real time sharing, and reporting via On-Demand or outright purchase model.
OptraSCAN’s Digital Pathology system comprises of small-footprint, low and high throughput WSI scanners well equipped for confocal, brightfield, fluorescence and frozen sections/live view mode, an integrated image viewer and image management system – IMAGEPath®, image analysis – OptraASSAYS™, a cloud-based LIMS – CLOUDPath®, and CARDS™ (computer aided region detection system). OptraSCAN’s integrated solutions include TELEPath™, a comprehensive telepathology solution and AI & ML- based automated image analysis solutions that have been developed to provide accurate assessment of nuclear and membrane biomarker, immuno-oncology and prostate cancer. Follow Us on LinkedIn and Twitter.
Contacts:
Media Inquiries:
Shruti Soman | Manager – Marketing Communications | 91.20.66540900 | s.soman@optraventures.com
Sales Inquiries:
Mike Oria | Director of Sales – North America | 415.407.9658 | mike@optraventures.com
Source: OptraSCAN
